Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	644.52	593.24	498.99	437.77	349.85	322.36
Other Revenue	68.37	51.16	-	-	-	-
Revenue	712.89	644.4	498.99	437.77	349.85	322.36
Revenue Growth (YoY)	31.80%	29.14%	13.98%	25.13%	8.53%	9.40%
Cost of Revenue	320.38	290.57	250.13	238.03	206.51	190.43
Gross Profit	392.51	353.82	248.86	199.74	143.34	131.92
Selling, General & Admin	88.15	80.39	66.59	67.12	62.86	63.11
Research & Development	71.78	73.74	74.77	60.93	67.23	68.85
Operating Expenses	159.92	154.13	141.36	128.05	130.09	131.96
Operating Income	232.59	199.69	107.5	71.69	13.25	-0.04
Interest Expense	-32.38	-27.16	-1.85	-0.89	-0.37	-0.12
Interest & Investment Income	9.4	5.46	1.32	0.6	0.64	1
Earnings From Equity Investments	-1.47	-1.98	-1.18	-0.21	-	-
Other Non Operating Income (Expenses)	-3.8	-3.93	3.67	13.54	6.22	-0.51
EBT Excluding Unusual Items	204.33	172.08	109.46	84.73	19.74	0.33
Asset Writedown	-2.7	-2.7	-	-	-	-
Legal Settlements	-	-	5.4	1	-12.8	59.9
Other Unusual Items	-	-	-	-1.8	-2.3	-
Pretax Income	201.63	169.38	114.86	83.93	4.64	60.23
Income Tax Expense	35.12	31.83	23.48	20.63	3.54	13.72
Earnings From Continuing Operations	166.52	137.55	91.39	63.3	1.1	46.51
Minority Interest in Earnings	-	-	-	-1.19	0.31	2.43
Net Income	166.52	137.55	91.39	62.12	1.4	48.94
Net Income to Common	166.52	137.55	91.39	62.12	1.4	48.94
Net Income Growth	63.34%	50.51%	47.12%	4327.37%	-97.13%	-
Shares Outstanding (Basic)	48	48	49	48	47	47
Shares Outstanding (Diluted)	53	53	52	50	49	50
Shares Change (YoY)	1.15%	1.09%	5.31%	1.34%	-1.57%	7.57%
EPS (Basic)	3.44	2.85	1.88	1.30	0.03	1.04
EPS (Diluted)	3.15	2.60	1.74	1.25	0.03	0.98
EPS Growth	62.07%	49.43%	39.20%	4090.97%	-96.96%	-
Free Cash Flow	178.13	145.34	65.15	70.54	23.41	0.21
Free Cash Flow Per Share	3.36	2.74	1.24	1.42	0.48	0.00
Gross Margin	55.06%	54.91%	49.87%	45.63%	40.97%	40.92%
Operating Margin	32.63%	30.99%	21.54%	16.38%	3.79%	-0.01%
Profit Margin	23.36%	21.34%	18.31%	14.19%	0.40%	15.18%
Free Cash Flow Margin	24.99%	22.55%	13.06%	16.11%	6.69%	0.06%
EBITDA	284.16	237.72	132.27	94.95	34.78	18.07
EBITDA Margin	39.86%	36.89%	26.51%	21.69%	9.94%	5.61%
D&A For EBITDA	51.57	38.04	24.77	23.27	21.53	18.11
EBIT	232.59	199.69	107.5	71.69	13.25	-0.04
EBIT Margin	32.63%	30.99%	21.54%	16.38%	3.79%	-0.01%
Effective Tax Rate	17.42%	18.79%	20.44%	24.58%	76.34%	22.79%
Revenue as Reported	712.89	644.4	498.99	437.77	-	-
Advertising Expenses	-	10.4	8.7	8.1	5.8	4.3

Source: S&P Capital IQ. Standard template. Financial Sources.